UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Position in REGN — Regeneron Pharmaceuticals, Inc.
CIK 861177
NEW YORK, NY
Position in REGN
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$559,098,523
-$16,124,467 QoQ
Shares Held
723,621
-2.9% QoQ
Ownership
0.690%
of shares outstanding
% of Portfolio
0.12%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 43.74306439420636.ToString("F0")%
Shared 0.ToString("F0")%
None 56.25693560579364.ToString("F0")%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds $4,287,037,771 across 211 Biotechnology names. REGN ranks #2 (13.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,057,396 | $1,365,249,602 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
723,621 | $559,098,523 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
677,519 | $224,170,706 | |
| 4 | INSM |
INSMED Inc
|
1,215,025 | $198,680,883 | |
| 5 | RPRX |
Royalty Pharma plc
|
3,095,766 | $148,503,890 | |
| 6 | INCY |
Incyte Corp
|
1,540,913 | $145,030,725 | |
| 7 | IONS |
Ionis Pharmaceuticals Inc
|
1,475,632 | $110,805,201 | |
| 8 | DNLI |
Denali Therapeutics Inc.
|
4,432,314 | $85,100,425 |
All Filings in REGN
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $559,098,523 | 723,621 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $575,222,990 | 745,233 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $418,426,147 | 744,173 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $451,731,525 | 860,441 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $596,389,294 | 940,336 | Shares | Defined | 2025-05-19 | |
| 2024-12-31 | $699,553,642 | 982,064 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $793,803,933 | 755,112 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $890,939,206 | 847,682 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $658,885,997 | 684,564 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $585,275,763 | 666,381 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $572,275,680 | 695,387 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $478,679,845 | 666,184 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $547,383,403 | 666,184 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $438,201,273 | 607,356 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $414,006,731 | 600,994 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $356,775,323 | 603,548 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $402,403,755 | 576,163 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $383,912,370 | 607,918 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $317,242,009 | 524,211 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $320,165,175 | 573,218 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $292,564,222 | 618,346 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $310,853,259 | 643,442 | Shares | Defined | 2021-03-01 | |
| 2020-09-30 | $331,501,150 | 592,199 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $313,107,843 | 502,057 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $163,133,289 | 334,091 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||